Janna Cazacu

Mrs. Janna Cazacu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2024 in Archives of the Balkan Medical Union
Verified
Journal Article
Open access
JCJanna Cazacu
Janna Cazacu
DLDorin Lîsîi
Dorin Lîsîi
OPOxana Priscu
Oxana Priscu
DBDaniela Bursacovschi
Daniela Bursacovschi
SDStela Dodu
Stela Dodu
MCMaria Costiuc
Maria Costiuc

1 June 2023 in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
Verified
Journal Article
Open access
PDF file
JCJanna Cazacu
Janna Cazacu
DBDaniela Bursacovschi
Daniela Bursacovschi
SDStela Dodu
Stela Dodu
EVEleonora Vataman
Eleonora Vataman
Background. Exercise capacity is strongly associated with morbidity, as well as all-cause and cardiovascular mortality in patients with heart failure. Right ventricular dysfunction (RVD) appears to be an independent predictor of exercise intolerance, but its influence on patients’ exercise capacitiy in the early period after myocardial revascularization remains unclear. Purpose: evaluation of exercise capacity in patients with DVD 3 months after myocardial revascularization. Methods. The research is a prospective analytical study which is part of the scientific project „ALTERICC” within the State Program 2020-2023. The research included 114 patients 3 months after myocardial revascularization by coronary artery by-pass grafting or percutaneous coronary angioplasty. They were divided into 2 groups according to the presence of RVD: Gr. RVD 35 patients and Gr. non-RVD -79 patients. All patients were investigated by echocardiography, cardiopulmonary exercise testing (CPET) and 6 minute walking test (6MWT).Results. Peak oxygen consumption (VO2p) achieved by patients in the RVD group was significantly lower (1018.0±400.6 ml/min) compared to those in the non-RVD group (1243.9±336, 6 ml/min), p<0.05. VO2p related to the maximum predicted value (VO2p%) was inferior in patients with RVD (49.2±13.3% vs 58.5±15.0%), p=0.01, as well as VO2p related to body mass was lower in the RVD group (VO2p/kg 11.9±3.9 ml/min/kg vs 14.6±4.1 ml/min/kg), p=0.01. S’ RV and TAPSE correlated positively and statistically significantly with VO2p, VO2p% and VO2p/kg. Patients with RVD performed a lower distance during 6MWT (313.5±72 m vs 338.1±65.5 m). However, the results of 6MWT correlatedpositively with the work rate performed during CPET and VO2p, VO2p/kg, VO2p%.Conclusion. Exercise capacity (expressed both by maximal work rate and by VO2p, VO2p/kg, VO2p%, but also by the distance performed during TM6M) was lower in patients with RVD at 3 months after myocardial revascularization.

1 June 2024 in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
Verified
Journal Article
Open access
PDF file
JCJanna Cazacu
Janna Cazacu
SDStela Dodu
Stela Dodu
DBDaniela Bursacovschi
Daniela Bursacovschi
EVEleonora Vataman
Eleonora Vataman
Pulmonary hypertension (PH) associated with left heart disease is common and has an important impact on disease progression, morbidity and mortality. We aimed to identify the particularities of PH evolution in patients with ischemic heart failure during 12 months after myocardial revascularization (MRev) by coronary artery bypass grafting or percutaneous coronary angioplasty.Methods: The research included 281 patients undergoing MRev (mean age=63.2±9.7 years, 76.5%- men). Follow up period - 12.6±1.6 months. The patients were divided according to the echocardiographic probability of PH (PHPr) into 3 groups: low PHPr (117 patients), intermediate PHPr (74 patients), high PHPr (90 patients). Results. The prevalence of PH 12 months after MRev constituted 69.7%, increasing by 10% compared to the initial period. We highlighted a negative evolution of PHPr during 1 year after MRev: 42.8% of patients with initially low PHPr and 54.1% of those with intermediate PHPr had a higher degree of PHPr. The peak tricuspid regurgitation velocity and the pulmonary artery systolic pressure did not change significantly during 12 months after the acute event. The negative evolution of PHPr was determined by the negative dynamics of additional echocardiographic signs suggestive for PH: the right atrium area (+2,2±0.4mm), the right ventricular outflow tract acceleration time (-7.6±1.2ms), the inferior vena cava diameter (+0.55±0.2mm). During 12 months after MRev, 5 patients died, all of them had high PHPr (p<0.01), and the hospitalization rate was significantly higher in this group (high PHPr - 57.1%, intermediate PHPr - 43.2%, low PHPr - 38.7%, p<0.05). Conclusions: The PH prevalence 12 months after MRev was 69.7%, increasing by 10% compared to the initial period. A negative evolution of PHPr was noted during 1 year follow up. Patients with high and intermediate PHPr had a higher rate of hospitalizations during the 12 months after MRev and all deceased patients had high PHPr.

1 October 2025
Verified
Journal Article
Open access
PDF file
JCJanna Cazacu
Janna Cazacu
EVEleonora Vataman
Eleonora Vataman
Introduction. Right ventricular dysfunction (RVD) is a prognostic factor for morbidity and mortality across a wide range of cardiovascular diseases. The aim of this research was to identify the predictors influencing the development of RVD in patients with ischemic heart failure (HF) 12 months after myocardial revascularization. Methods. The research was a prospective study that included 275 patients with ischemic HF, assessed at 3 and 12 months after myocardial revascularization (coronary artery bypass grafting - 54.5%, percutaneous coronary intervention - 45.5%). NT-proBNP evaluation, echocardiography and cardiopulmonary exercise testing was performed. Patients were divided into two groups based on the detection of de novo RVD at the end of the study. Results. The RVD rate was 39.2% and 49.2% in the studied cohort at 3 and 12 months post-myocardial revascularization, respectively. De novo RVD was identified in 19.9% of the study population. The prognostic factors that influenced the development of RVD during the studied period were: duration of ischemic heart disease, stage C AHA/ACC of HF, left atrial diameter, left ventricular end-diastolic diameter, left ventricular ejection fraction, wall motion score, peak tricuspid regurgitation velocity, right atrial area, right ventricular outflow tract acceleration time, TAPSE/PASP ratio, pulmonary vascular resistance assessed by echocardiography and VE/VCO2 slope. Discriminant analysis enabled the development of a predictive model for de novo RVD over 12 months after myocardial revascularization, based on 4 parameters: duration of ischemic heart disease, HF stage according to the AHA/ACC classification, right atrial diameter and left ventricular end-diastolic diameter. This model allows the accurate prediction of de novo RVD in 62.2% of cases. Conclusion. The rate of de novo RVD at 12 months after myocardial revascularization was 19.9%. Key echocardiographic parameters of pulmonary hypertension and HF syndrome demonstrated a significant prognostic impact on RVD development at the end of the first year after the acute cardiac event.

21 March 2025 in Archives of the Balkan Medical Union
Verified
Journal Article
Open access
JCJanna Cazacu
Janna Cazacu
CJConstantin Jucovschi
Constantin Jucovschi
EVEleonora Vataman
Eleonora Vataman

1 November 2025
Verified
Journal Article
Closed access
DLDorin Lisii
Dorin Lisii
JCJanna Cazacu
Janna Cazacu
SFSilvia Filimon
Silvia Filimon
AGAliona Grivenco
Aliona Grivenco
OPOxana Priscu
Oxana Priscu
EVEleonora Vataman
Eleonora Vataman
Purpose. description and analysis of the hospitalized patients with acute heart failure, who were included in the ESC Heart Failure Long-Term Registry Republic of Moldova (ESC-HF-LT Registry RM), their gender differences and the evolution of adherence to optimal drug treatment over the last ten years in the RM. Material and methods. The study group consisted of 254 patients older than 18 years, hospitalized with acute heart failure (HF) during the period 2011 - 2014 in 2 centers in the Republic of Moldova. Results. The majority of hospitalized patients were men (64.9%), with a higher mean age in women. The main cause of HF was ischemic heart disease. Arterial hypertension was more common in women: 80.9% vs 67.9% in men, p less than 0.05, but among men there were fewer smokers and alcohol drinkers. The main cause of admission was exacerbated heart failure, in patients included in the ESC-HF-LT registry. The mean LV EF values were higher in women: 44.1% vs 37.3% in men, p less than 0.01. Mortality and readmission rates at 12 months were similar in the female and male patient groups. Conclusion. The clinical characteristics and 12-month outcomes of patients hospitalized with heart failure in the Republic of Moldova were similar compared to patients from other countries included in the ESC Heart Failure Longterm Registry. The rate of drug prescription for the optimal treatment of heart failure in recent years has been high, especially for ACE inhibitors/ARBs and beta-blockers, with a positive trend in the prescription of SGLT-2 inhibitors.